-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $305

Benzinga·11/09/2026 17:13:15
Listen to the news
Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $230 to $305.